Sourasky Medical Center (Ichilov)
| Израиль | Түркия | Австрия | |
| Юинг саркомасын кешенді емдеу | бастап $67,500 | бастап $30,000 | бастап $55,000 |
| Туыстық емес донордан алынған жұлың кемігін аллогендік трансплантациялау | бастап $135,000 | бастап $80,000 | бастап $180,000 |
| Туыстық донордан алынған сүйек кемігін аллогендік трансплантациялау | бастап $142,000 | бастап $65,000 | бастап $150,000 |
| Сәулелік терапия | бастап $12,500 | бастап $6,000 | бастап $12,000 |
| Сүйек кемігін трансплантациялау | бастап $144,000 | бастап $36,000 | бастап $140,000 |
Сіз Bookimed қызметтері үшін төлемейсіз. Сайттағы балалар онкологиясының емдеудің бағалары клиниканың баға тізіміне сәйкес келеді. Сіз жеткенде тікелей клиникада төлейсіз. Бөліктермен төлеу қолжетімді.
Bookimed Сіздің қауіпсіздігіңізді қамтамасыз етеді. Біз тек балалар онкологиясының жүргізу үшін жоғары халықаралық стандарттарға сәйкес келетін клиникалармен ғана жұмыс істейміз. Олардың бүкіл әлем бойынша халықаралық науқастарға қызмет көрсету үшін қажетті лицензиялары бар.
Bookimed тегін көмек және қолдау ұсынады. Жеке медициналық координатор сапарға дейін, кезінде және кейін Сізбен байланыста. балалар онкологиясына бойынша процедураларды өткенде Сіз әрқашан біздің қолдауымызға сене аласыз.
Клиника Ассута (Assuta) — Израильдегі ең ірі жеке медициналық орталық. Госпиталь онкология, ортопедия, нейро-, кардиохирургия және бедеулікті емдеуге маманданған. Елдегі барлық операциялардың 13% Ассутада өткізіледі, бұл оны хирургия бойынша жетекші орталық етеді.
Емдеудің сапасы мен қауіпсіздігі үшін аурухана американдық Joint Commission International аккредитациясын алды.
Әр жыл сайын Ассута желісінің дәрігерлері 92 000-нан астам операция, 685 000 диагностикалық процедура және 16 000 ЭКО циклдарын өткізеді.
Балаларда 300-ден астам жілік майы мен кіндік қанын трансплантаттау жүргізілді – доктор Эль Хасид Дана Дуэк балалар ауруханасындағы балалар онкогематология бөлімін басқарады.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.
She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.
She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.
She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.
Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.
He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.
Primary pediatric treatments in Israel center on advanced oncology and hematology protocols. Highly specialized children's hospitals provide leukemia chemotherapy, bone marrow transplants, and robotic surgery for solid tumors. These facilities utilize Joint Commission International (JCI) standards to ensure high-quality, clinical care for complex cases.
Bookimed Expert Insight: Israeli pediatric centers show a unique pattern of surgical collaboration. At Sourasky, neurosurgeons and orthopedic specialists co-manage bone cancers. This integrated approach allows for more complete tumor removal in complex cases. Such cooperation is common in hospitals serving 11,000+ children annually.
Patient Consensus: Parents note that treatment protocols match top international standards. They appreciate that major centers provide multilingual staff and housing to support families during long-term stays.
Israeli pediatric oncology distinguishes itself through family-centric infrastructure and specialized long-term monitoring. Doctors prioritize outpatient ambulatory care to maintain normal childhood development. Dedicated centers like the Schneider Center for Children Medicine and Hadassah Medical Center employ higher safety standards, including positive pressure entranceways, to protect immunocompromised children.
Bookimed Expert Insight: Israeli pediatric centers show a unique pattern where primary oncologists, like Dr. Gal Goldstein at Hadassah, manage the entire patient journey. This contrasts with adult care, where patients often move between multiple specialists. This continuity ensures that complex histories involving rare blood cancers or retinoblastoma are never lost during transitions, a common challenge in high-volume adult wards.
Patient Consensus: Parents find that pediatric units treat them as equal care partners and involve children in age-appropriate medical discussions. Many note it is helpful that hospitals coordinate with schools to keep children from falling behind in their education during intensive treatments.
Children in Israel have direct access to international clinical trials through major research hospitals. Facilities like Sourasky Medical Center and Hadassah Medical Center participate in global networks. These include the Children's Oncology Group (COG). They also work with the International Society of Pediatric Oncology (SIOP).
Bookimed Expert Insight: Israeli pediatric centers often lead in trial availability due to high patient volumes. Hadassah and Sheba each serve over 1,000,000 patients annually. This scale attracts international sponsors for rare disease studies. Patients at these centers often access targeted therapies earlier than in smaller regional hospitals. Always check if a trial is active at your specific diagnosis date.
Patient Consensus: Parents note that trial participation is highly selective and based on strict timing. They recommend asking for an explicit list of active trials immediately at diagnosis. Many found that navigating consent forms may require translation support as some documentation is in Hebrew.
International families in Israel access non-medical support through hospital social departments, non-governmental organizations (NGOs), and specialized international patient centers. These services include subsidized housing, linguistic mediation, and bureaucratic guidance. Facilities like Hadassah Medical Center and Sourasky Medical Center provide dedicated coordinators to assist with logistics and integration.
Bookimed Expert Insight: Data from high-volume centers like Hadassah Medical Center, serving 1,000,000 patients annually, shows a sophisticated support infrastructure. Families often overlook that private clinics like Assuta Medical Center allow patients to choose specific physicians. This flexibility extends to recovery environments, which can significantly lower the stress of long-term pediatric oncology stays.
Patient Consensus: Parents emphasize that a local support person is essential for navigating insurance and bureaucratic delays. Finding hospital-affiliated lodging early is a top priority, as rental costs are a major financial drain.
Parents in Israel are encouraged to stay with their child 24/7 during pediatric oncology treatment. Hospitals like Sourasky Medical Center and Hadassah Medical Center provide in-room accommodations. This family-centered approach supports recovery during intensive procedures like chemotherapy or bone marrow transplantation.
Bookimed Expert Insight: Israeli pediatric centers prioritize parental presence as a clinical necessity rather than a luxury. Facilities like the Schneider Center for Children Medicine, which serves 275,000 patients annually, integrate family spaces directly into ward designs. Our data shows that clinics with high international volumes often coordinate these logistics through dedicated social workers to ensure seamless transitions for traveling families.
Patient Consensus: Patients note that staying overnight is socially expected in Israel, with nurses providing comfy chair-beds for parents. One parent mentioned it is helpful to pack for a 24/7 stay as facilities like laundry and showers are usually located right next to the ward.
English is widely spoken by medical specialists in Israeli pediatric oncology departments. Most physicians hold international certifications or have trained in the United States and Europe. While doctors are fluent, English proficiency among nursing and administrative staff varies by facility and location.
Bookimed Expert Insight: Our data shows a clear trend in Tel Aviv clinics like Sourasky (Ichilov). These centers treat over 400,000 patients annually and have dedicated international departments. This high volume of foreign cases means that pediatric oncology units are better equipped with English-speaking coordinators than smaller regional hospitals like those in Haifa.
Patient Consensus: Parents note that while oncologists communicate complex details clearly in English, daily interactions with receptionists can be difficult. Many suggest requesting an English-speaking liaison during the first appointment to handle administrative tasks and discharge paperwork.
Израильдік ауруханалық қызметтер Шаббат кезінде де жұмысын жалғастырады. Еврей заңы Пикуах Нефеш принципі арқылы өмірді құтқаруды басты мақсат деп санайды. Бұл медициналық көмекке қатысты діни тыйымдарды жоққа шығарады. Хадасса медициналық орталығы сияқты орталықтардағы балалар онкология бөлімшелері 24/7 негізгі химиотерапия және мониторинг жүргізуді жалғастырады.
Bookimed сарапшы пікірі: Израильдік медициналық орталықтар сүйек кемігінің трансплантациясы сияқты күрделі процедураларды көбіне жексенбі мен бейсенбі аралығында жоспарлайды. Біздің мәліметтеріміз бұл әкімшілік және зертханалық қолдауды критикалық алғашқы 48 сағатта толық қамтамасыз ететінін көрсетеді. Сураски медициналық орталығы сияқты мекемелер онкологиядағы 90% жетістік көрсеткіштерін сақтау үшін осы уақытты басымдылықпен таңдайды.
Пациенттік консенсус: Пациенттер медициналық көмек үзілмей сақталғанымен, қоғамдық көлік тоқтайтындықтан, тасымалдаудың қиындайтынын байқайды. Олар жеке такси жалдауды немесе жұма күнінің түстен кейінінен бастап сенбі түнге дейін аурухана маңында болуды ұсынады.